How much funding has Antidote Therapeutics raised?

Antidote Therapeutics has disclosed $632.3K raised across 2 rounds.

Where is Antidote Therapeutics headquartered?

Antidote Therapeutics is headquartered in Gaithersburg, US.

Antidote Therapeutics

Gaithersburg, US · Founded 2013 · Delaware corporation

Antidote Therapeutics is a biotechnology company focused on drug discovery and development, led by an experienced team with backgrounds in clinical trials, pharmaceutical development, and biomarker-driven innovation.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Matthew KalnikFounder and Chief Executive Officer

Kenneth C. CarterNamed on SEC filing

Matthew W. Kalnik, PhDNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$632.3K disclosed across 2 rounds · 2017

▶$200KraisedSep 2017 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Kenneth C. CarterDirector
Matthew W. Kalnik, PhDExecutive Officer, Director

Offering amount: $200K
Amount sold: $200K
First sale: Jun 2017
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$432.3KraisedSep 2017 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Kenneth C. CarterDirector
Matthew W. Kalnik, PhDExecutive Officer, Director

Offering amount: $432.3K
Amount sold: $432.3K
First sale: Aug 2017
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

UPMC8 shared keywordsUPMC is a regional healthcare provider that invests in community health through charity care, free and subsidized health programs, and support for seniors, veterans, and food-insecure populations.

Companies competing with Antidote Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Attenuating nicotine’s effects with high affinity human anti-nicotine monoclonal antibodies | PLOS Onejournals.plos.org · Jul 2021

Frequently asked questions

What does Antidote Therapeutics do?: Antidote Therapeutics is a biotechnology company focused on drug discovery and development, led by an experienced team with backgrounds in clinical trials, pharmaceutical development, and biomarker-driven innovation.
How much funding has Antidote Therapeutics raised?: Antidote Therapeutics has disclosed $632.3K raised across 2 rounds.
Where is Antidote Therapeutics headquartered?: Antidote Therapeutics is headquartered in Gaithersburg, US.